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Abstract 
The unfolded protein response (UPR) is a highly conserved pathway that allows the 
cell to cope with endoplasmic reticulum (ER) stress imposed by the secretory 
demands associated with environmental forces. In this role, the UPR has 
increasingly been shown to have crucial functions in immunity and inflammation. In 
this Review, we discuss the importance of the UPR in the development and 
differentiation of immune cells, its role in immune cell function and its crucial role in 
the ability of immune cells to survive and thus meet the needs associated with an 
immune response.  In addition, we review current insights into how the UPR is 
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involved in complex chronic inflammatory diseases and, through its role in immune 
regulation, anti-tumour responses. 
 
Introduction 
The endoplasmic reticulum (ER) is an extensive tubular-reticular network, 
separated from the surrounding cytosol by a single lipid bilayer, the ER membrane. 
It is a crucial site involved in maintaining Ca2+ homeostasis and its major function is 
the synthesis and folding of secreted and transmembrane proteins, which constitute 
approximately one third of all proteins made in the cell.1,2 Following translation on 
ER membrane-associated ribosomes, proteins enter the ER lumen where 
chaperone-based folding occurs, together with complex protein modifications. 
These include N-linked glycosylation, disulfide bond formation and proline cis-trans 
isomerization, which are mediated by glycosyltransferases, oxido-reductases and 
peptidyl-prolyl cis-trans isomerases, respectively. 3-6 
Adequate folding and posttranslational modifications of proteins crucial for proper 
function; furthermore, in a dominant manner, misfolded and aggregated proteins 
can cause cellular stress and cell death, as exemplified by neurodegeneration and 
other protein misfolding diseases.7,8 It is therefore of crucial importance that 
protein folding is subject to stringent quality control systems to allow a cell to carry 
out its necessary secretory functions. As an example, ER-associated degradation 
(ERAD) [G] ensures that mis- and unfolded proteins are removed from the ER lumen 
to the cytosol for subsequent degradation by the ubiquitin–proteasome system.9 
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Numerous environmental conditions, both endogenous and exogenous, can disrupt 
the ER protein-folding environment, and when protein folding requirements exceed 
the processing capacity of the ER, mis- and unfolded proteins accumulate in the ER 
lumen, triggering the unfolded protein response (UPR) [G]. The UPR is a 
sophisticated collection of intracellular signaling pathways that have evolved to 
respond to protein misfolding in the ER. In addition, it has become increasingly clear 
that UPR signaling has an important role in immunity and inflammation. In this 
Review, we discuss the role of UPR activation in the development of immune cells 
and how the UPR is involved in building efficient immune responses. In addition, we 
highlight causes of UPR activation that are directly linked to inflammation and 
review current insights into the downstream pathways by which UPR activation 
induces inflammation. Lastly, we discuss how the UPR is involved in various 
prevalent diseases, including inflammatory bowel disease, metabolic disease and 
cancer. Due to the breadth of this Review, we do not provide significant detail for 
individual sections but have attempted to provide an overview of the most relevant 
and recent findings. 
 
[H1] The unfolded protein response pathway 
In metazoans, the UPR is activated by the coordinate action of three ER 
transmembrane stress sensors: inositol-requiring enzyme 1  (IRE1 ), PKR-like ER 
kinase (PERK) and activating transcription factor 6  (ATF6 ). Under homeostatic 
conditions, the luminal domains of these ER stress sensors are retained in an 
inactive state through association with binding immunoglobulin protein (BiP; also 
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known as GRP78 and HSPA5). However, due to its higher affinity for misfolded 
proteins, BiP dissociates from the ER stress sensors as misfolded proteins 
accumulate, thereby releasing the stress sensors to permit downstream signaling 
(Figure1).10 In addition, it has been elegantly shown that, at least in Saccharomyces 
cerevisiae, basic and hydrophobic residues on unfolded proteins can bind directly to 
a putative peptide groove of IRE1  and direct binding of unfolded proteins is 
sufficient to induce the UPR.11 At present it is unclear whether direct binding of 
unfolded proteins as a second mechanism of UPR activation is limited to IRE1, or 
can also be observed with PERK and ATF6 . These mechanisms require further 
characterization.  
The downstream transcriptional programmes of the UPR are primarily directed at 
restoring proteostasis, which is achieved by at least four different strategies. First, 
mRNA translation is transiently attenuated through PERK-dependent 
phosphorylation of the alpha subunit of eukaryotic translation initiation factor 
(eIF2 ) which inhibits assembly of the eIF2-GTP-Met-tRNA ternary complexes 
(eIF2-TC), and thereby reduces the quantity of proteins that enter the ER, Second, 
entry of newly translated proteins into the ER is decreased by degradation of ER 
membrane-associated mRNAs by regulated IRE1 -dependent decay (RIDD).12-14 
Third, processes that eliminate unfolded proteins from the ER are induced, by 
increasing the transcription of ERAD- and autophagy-related proteins (see also BOX 
1). Finally, genes are induced that increase protein folding capacity and expansion 
of the ER through increased biogenesis of ER and lipid components.1,15 
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However, when these attempts to restore proteostasis fail and ER stress is 
unabated, UPR signaling typically switches to a pro-apoptotic mode, a process that is 
also referred to as the terminal UPR [reviewed in REF 16].16 The terminal UPR may 
have evolved to eliminate excessively damaged or pathogen-infected cells, for 
example.  
 
[H3] IRE1 . 
The cytoplasmic tail of the type I transmembrane protein IRE1  possesses two 
enzymatic activities: a serine/threonine kinase domain and an endoribonuclease 
(RNase) domain.17 Upon release from BiP, dimerization of IRE1  elicits RNase 
activity to initiate the non-conventional splicing of a single mRNA encoding X-box 
binding protein 1 (XBP1) to produce a translational frameshift and create a potent 
transcriptional activator known as XBP1s (‘s’ for spliced). 18 19 XBP1s translocates to 
the nucleus where it induces the transcription of a wide variety of ER-resident 
molecular chaperones and protein-folding enzymes that together expand ER size 
and function (Figure 1A).15,20 In addition to its specific endoribonuclease activity 
that splices Xbp1, IRE1 -dependent activation of RIDD is proposed to degrade ER-
membrane-associated mRNAs to reduce the amount of protein entering the 
secretory pathway (Figure 1A).21 In addition, emerging evidence indicates that 
RIDD substrates encode proteins of diverse nature, which modulate cellular 
processes that are distinct from the control of ER homeostasis, including the 
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generation of inflammatory double-stranded RNA species through activation of 
intracellular nucleic acid sensors.22,23 
During prolonged ER stress, the beneficial effects of IRE1 activation through the 
activity of XBP1s may be temporally and quantitatively impeded, while the PERK 
pathway becomes dominant.24,25 In addition, chronic ER stress increases the 
oligomerization state of IRE1  to hyperactivate its cytosolic RNase domains, which 
leads to cleavage of many other RNAs besides Xbp1, including precursors of 
apoptosis-inhibitory microRNAs, which thus promotes apoptosis.26-28 Therefore, 
prolonged ER stress may tend to tip the properties of IRE1 from being adaptive to 
promoting inflammation and cell death. 
 
[H3] PERK. 
Similarly to IRE1 , dissociation of BiP from the ER luminal domain of PERK permits 
PERK homodimerization and autophosphorylation to activate the cytoplasmic 
kinase domain. In addition, it was shown that the lipid composition of the ER 
membrane can also activate PERK, which highlights the significance of lipid 
metabolism as a direct trigger of UPR activation.29,30 Activated PERK phosphorylates 
eIF2  which inhibits eIF2-TC formation and thereby transiently attenuates global 
mRNA translation, enabling the cell to cope with temporary ER stress (Figure 1B). 
Of note, eIF2  can be phosphorylated in mammals independently of ER stress, by 
three additional kinases: general control nonderepressible 2 (GCN2), which is 
induced by amino acid deprivation; the heme-regulated inhibitor kinase (HRI), 
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which is induced by oxidative stress or heme deprivation; and the protein kinase R 
(PKR), which is activated by double-stranded RNA as part of the interferon antiviral 
response.31   Together, these additional mechanisms of eIF2  phosphorylation form 
the integrated stress response (ISR) [G] system, which allows the cell to integrate 
multiple stress stimuli into one common node, that being the general control of 
protein synthesis through phosphorylation of eIF2 31 As an example, both 
epithelial cells and dendritic cells activate GCN2 to phosphorylate eIF2  in response 
to amino acid deprivation, to induce autophagy, reduce oxidative stress and inhibit 
inflammasome activation.32 
While translation of most RNAs is inhibited in ER stressed cells, translation of some 
species of mRNA is favoured under ER stress conditions, when eIF2 is 
phosphorylated and eIF2-TC availability is low (mechanisms reviewed in reference 
33).33.34 One important example is the mRNA encoding activating transcription 
factor 4 (ATF4; also known as CREB2), a crucial UPR mediator that transactivates 
genes involved in amino acid metabolism and oxidative stress resistance, as well as 
autophagy (Figure 1B).12 As a sustained translational block is not compatible with 
cell survival, ATF4 also induces Ppp1r15a expression, which encodes GADD34, a 
regulatory subunit of protein phosphatase 1 (PP1) that directs the 
dephosphorylation of eIF2  to restore mRNA translation (Figure 1B). However, 
ATF4 also activates transcription of C/EBP homologous protein (CHOP),12,35 which 
is involved in ER-stress-mediated apoptosis both in vitro and in vivo.36,37 To allow 
the cell a chance to cope with the ER stress, several mechanisms suppress CHOP at 
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early times after ER stress, such as PERK-dependent miR-211 expression, which 
represses CHOP transcription through histone methylation.38 In addition, CHOP is 
suppressed by Toll-like receptor (TLR) signaling during immune responses in 
macrophages by protein phosphatase 2A (PP2A)-mediated serine 
dephosphorylation of the eIF2Bε subunit.39 Indeed, only strong and chronic 
activation of PERK increase steady-state levels of CHOP, due to the short half-life of 
both ATF4 and CHOP mRNAs and proteins, so that only excessive ER stress will 
promote the terminal UPR.40 Studies of ATF4 and CHOP in cells experiencing chronic 
ER stress indicate that they function together as a heterodimer to induce apoptosis 
by increasing protein synthesis, thereby enhancing protein misfolding and oxidative 
stress and cell death.41 
 
[H3] ATF6. 
ATF6 is a type II transmembrane protein that contains a bZIP transcription factor 
within its cytosolic domain. Although there are two ATF6 genes in the mammalian 
genome (ATF6A and ATF6B), only ATF6  is required to activate UPR gene 
expression.42 Upon release from BiP, ATF6  transits to the Golgi compartment 
where it is processed by the Golgi enzymes site 1 protease (S1P) and S2P to produce 
a cytosolic p50 fragment that migrates to the nucleus. The p50 fragment activates 
expression of genes that encode functions to increase ER capacity and folding 
(including BiP, Grp94, P58IPK and Xbp1) and the ERAD pathway (Figure 1C).19,42-44 
 
[H1] The physiological UPR in immune cell differentiation and function 
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Cells that have a large secretory demand as part of their function are particularly 
dependent on a well-developed and large ER and, consequently, UPR signaling. It is 
therefore not surprising that highly secretory immune cells are highly susceptible to 
environmental conditions that impose ER stress, either by directly targeting ER 
folding capacity (for example, microbial toxins)45 or markedly increasing folding 
demand (for example, exposure to pathogens). Thus, inflammation per se is an 
important factor in ER stress induction, and UPR activation may be a sensitive 
hallmark of inflammation. In addition to the pathophysiological conditions that 
affect specific cell types, it is now well established that activation of the UPR has a 
role in a wide range of physiological events associated with immunologically 
important cell types.46 Furthermore, although they have not been well studied, 
germline polymorphisms or, potentially, somatically generated mutations may affect 
the ability of the host to determine whether an appropriate UPR level is achieved 
based upon the demand. Understanding how the UPR affects specific functions at 
the cellular level and the host-related factors that affect this are therefore of great 
importance, as considered below. 
 
[H3] B cells and plasma cells 
Over the past 15 years, the role of the transcription factor XBP1 in B cell and plasma 
cell differentiation has become increasingly clear and has served as a paradigm for 
numerous secretory systems and their relationships to immune function and 
inflammation. Plasma cell differentiation is regulated by the transcription factors 
interferon-regulatory factor 4 (IRF4) and B lymphocyte-induced maturation protein 
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1 (BLIMP1).47,48 In addition, induction of Xbp1, which is downstream of BLIMP1, is 
required for the marked expansion of the ER and increased protein synthesis that 
are necessary for high levels of antibody production and secretion during a 
physiological or pathological immune response (Figure 2A).49,50 Indeed, XBP1 
deficiency in B cells leads to an absence of plasma cells and markedly reduces 
circulating antibody levels, but has no effect on B cell maturation or isotype 
switching.51 Although it was initially assumed that XBP1 induction was caused by 
increased immunoglobulin synthesis and the accumulation of unfolded 
immunoglobulin heavy chains,52 subsequent studies have shown that ER expansion 
is evident before the onset of immunoglobulin synthesis53 and Xbp1 is similarly 
spliced when IgM secretion is genetically abrogated.54  This suggests that XBP1 
induction is a differentiation-dependent event in plasma cells, rather than a 
response to increased immunoglobulin secretion. The factors that drive UPR 
activation early during plasma cell development are incompletely understood. Of 
note, part of the decrease in immunoglobulin production in XBP1-deficient B cells 
was later explained by IRE1  hyperactivation leading to increased RIDD and the 
subsequent degradation of immunoglobulin  heavy-chain mRNAs.55 
In addition to plasma cells, IRE1  activation is also observed in pro-B cells.56 UPR 
activation in these early stages of B cell development might result from increased 
secretory demand caused by neo-expression of cell surface proteins associated with 
V(D)J antigen receptor rearrangements.57 Indeed, a recent study shows that IRE1  
and XBP1s are important during the pre-B cell stage when immunoglobulin heavy 
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chains are expressed for the first time and, importantly, that XBP1s in pre-B acute 
lymphoblastic leukemia (ALL) cells provides a survival benefit for tumour cells.58  
 
[H3] T cells 
Studies with XBP1s-GFP reporter mice have shown that IRE1  is activated in 
CD4+CD8+ thymic T cells and in CD8+ splenic T cells, although the precise role of the 
UPR in early T cell development is not clear.56 However, activation of the IRE1 –
XBP1 axis in effector CD8+ T cells was reported in response to acute infection with 
Listeria monocytogenes, which was associated with expression of high levels of killer 
cell lectin-like receptor G1 (KLRG1). This suggests that XBP1 is important for the 
terminal differentiation of effector CD8+ T cells.59 
 
[H3] Dendritic cells 
Xbp1 is constitutively spliced in dendritic cells (DCs), and loss of XBP1 leads to 
significantly reduced numbers of both conventional and plasmacytoid DCs. (Figure 
2B, left panel).60 In addition, XBP1-deficient DCs have increased rates of apoptosis 
and are resistant to survival signals associated with TLR engagement (Figure 2B, 
left panel). Interestingly, ectopic expression of XBP1s in XBP1-deficient FLT3+ 
hematopoietic progenitor cells can rescue this apoptotic phenotype.60 Taken 
together, this study shows that XBP1 is important for DC development and survival.  
Consistent with the findings above, constitutive activation of IRE1  is observed in 
DCs61 using ER stress-activated indicator (ERAI) reporter mice.62 Interestingly, 
although the highest levels of IRE1  activity are observed in CD8 + DCs, deletion of 
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XBP1 in DCs using CD11c-directed Cre does not result in developmental and 
phenotypic abnormalities of CD8 + DCs. This different result compared with the 
study of Iwakoshi et al.60 may be explained by low levels of expression of CD11c, and 
hence Cre recombinase activity, in DC progenitor cells. Interestingly, however, 
XBP1-deficient CD8 + DCs generated by CD11c-Cre-mediated deletion of Xbp1 have 
RIDD-dependent defects in cross-presentation to OT-I T cells, owing to degradation 
of components of the cross-presentation machinery such as tapasin.61 This study 
shows that the IRE1 –XBP1 arm of the UPR is crucially involved in DC function. 
(Figure 2B, right panel). 
Consistent with a role for ER stress in regulating antigen presentation, several other 
studies have shown that ER stress affects the surface expression of MHC class I 
molecules by mechanisms that are not fully elucidated as yet. 63,64 In ovarian cancer, 
impaired MHC class I-restricted antigen presentation to CD8+ T cells has been linked 
to reactive oxygen species (ROS)-induced ER stress and increased lipid metabolism 
in DCs induced by an unknown transmissible stress factor in the tumor 
microenvironment. While the concept of lipid accumulation-dependent dysfunction 
of DC antigen presentation had been described previously,65  this study links ER 
stress-induced Xbp1 splicing to lipid accumulation in DCs,  resulting in DC antigen 
presentation defects (Figure 2B, right panel).66. [Note: we felt that this pathway 
should also be stressed in Figure 2, as it shows that also increased XBP1s can 
result in cross presentation defects] In accordance with this, deletion of XBP1 in 
DCs abolished the accumulation of lipid in DCs and increased T cell anti-tumour 
immunity, resulting in decreased tumour burden and improved survival.66  
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[H3] Granulocytes 
Granulocytes are represented by neutrophils, basophils and eosinophils. Eosinophils 
are typically associated with type II immune responses, allergy and parasitic 
infections.67 Recently, it has also been shown that eosinophils might have a role in 
maintaining immune homeostasis in the intestine by promoting IgA class switching 
in Peyer’s patches and controlling the pool of CD103+ T cells and DCs.68 
Interestingly, amongst all types of granulocyte, eosinophils are uniquely dependent 
upon XBP1 in that haematopoietic deletion of Xbp1 (Xbp1Vav1 mice) leads to a loss of 
fully mature eosinophils. In addition, deletion of Xbp1 specifically in eosinophils 
using Epx-Cre-mediated Xbp1 deletion results in a significantly smaller bone 
marrow eosinophil pool, which indicates that XBP1 is also needed to sustain the 
viability of eosinophil-committed progenitor cells.69 
 
[H3] Macrophages 
In macrophages, TLR signaling induces ER stress, and ER stress, in turn, amplifies 
the response to TLR ligation. For example, TLR2 and TLR4 ligands Pam3CSK4 and 
lipopolysaccharide (LPS), respectively, induce IRE1  activation in mouse J774 
macrophages. Furthermore, treatment with TLR agonists increases Xbp1 splicing, 
which is dependent on TNF receptor-associated factor 6 (TRAF6) recruitment to 
IRE  and requires the NAPDH oxidase NOX2.70 Importantly, IRE1 -induced Xbp1 
splicing in response to TLR ligation has been shown to be crucial for cytokine 
production as macrophage-specific deficiency of XBP1 impairs the production of 
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interleukin-6 (IL-6), tumor necrosis factor (TNF) and interferon-  (IFN )(Figure 
3A).70  
TLR signaling also amplifies IRE1  signaling by modulating its phosphorylation 
status. In the absence of TLR signaling, phosphorylated IRE1  is dephosphorylated 
and thus inactivated by PP2A. Upon TLR ligation, however TRAF6, interaction with 
IRE1  catalyzes its ubiquitylation, which prevents the interaction of IRE1  with 
PP2A through its adaptor receptor for activated C kinase 1 (RACK1) to avoid IRE1  
dephosphorylation and inactivation (Figure 3B).71,72 By contrast, induction of ER 
stress in bone marrow-derived macrophages strongly potentiates LPS-induced pro-
inflammatory signaling, including the induction of genes encoding CXCL1, CXCL2, 
TNF, IL-1  and IL-6, in a pathway dependent on receptor-interacting 
serine/threonine-protein kinase 1 (RIPK1).73  
The IRE1 –XBP1 pathway has also been linked to increased IL-1  production 
through IRE1 -dependent activation of glycogen synthase kinase 3  (GSK3 ). In 
addition, GSK3  inhibits further Xbp1 slicing and thereby Tnf transcription, which 
modulates the inflammatory response to ER stress and potentially TLR signaling 
(Figure 3C).74  
The PERK pathway has been shown to induce inflammation through direct binding 
of ATF4 to the Il6 promotor.75 In macrophages, however, TLR signaling inhibits 
translation of Atf4 mRNA and thereby its downstream target CHOP.76 Similarly, 
CHOP is further suppressed by TLR–TRIF signaling in macrophages through PP2A-
mediated serine dephosphorylation of the eIF2Bε subunit.39 These mechanisms of 
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CHOP suppression are required for macrophage survival during an immune 
responses. This demonstrates that specific control of the different arms of the UPR 
is crucial for innate immune function (Figure 3A).70  
 
[H3] Paneth cells. 
Conditional deletion of Xbp1 in intestinal epithelial cells (IECs) has shown that 
Paneth cells [G], which are an important source of anti-microbial peptides and stem 
cell survival signals,77  and to a lesser extent goblet cells that are dedicated to mucus 
production, are highly dependent on this UPR transcription factor.78 Paneth cells in 
mice with specific deletion of XBP1 in IECs are severely hypomorphic. The resultant 
decreased antimicrobial function has been shown to be associated with attenuated 
killing of L. monocytogenes and increased bacterial translocation to the liver. In 
addition, IRE1  hyperactivation leading to phosphorylation of JNK is also observed 
in XBP1-deficient intestinal epithelium, resulting in spontaneous superficial small 
intestinal enteritis (Figure 4) .78 Moreover, deletion of Xbp1 specifically in Paneth 
cells is sufficient to induce small intestinal enteritis.79 As the spontaneous 
inflammation observed in the setting of IEC-specific deletion of Xbp1 is reversed 
under germ-free conditions, these studies indicate that the UPR in IECs and, 
particularly, in Paneth cells is crucial to the maintenance of intestinal homeostasis in 
the presence of microbial commensalism. Whether XBP1 has a crucial role in the 
development of Paneth cells, as in highly secretory haematopoietic cells, is not fully 
clear.  
 
 16 
[H1] ‘Pathological’ causes of UPR activation 
It is clear that the UPR has a crucial function under physiological conditions, 
particularly during periods of high secretory demand, as shown by the loss of 
numerous haematopoietic cells (such as dendritic cells, eosinophils and plasma 
cells) and parenchymal cells (such as hepatocytes, pancreatic  cells, acinar cells of 
the salivary glands and Paneth cells) when critical elements of the UPR are absent.80  
In addition to this physiological UPR, ER stress can further result from various 
intrinsic and environmental factors, such as inadequate energy supply (as observed 
during hypoxia and nutrient deprivation) and increased secretory demand during 
exposure to pathogens and inflammatory stimuli.81  These environmental challenges 
induce UPR activation and thereby contribute to inflammation through various 
mechanisms.  
 
[H3] Hypoxia 
Hypoxia inhibits oxygen-dependent protein folding processes, which directly affects 
disulfide bond formation during post-translational folding of proteins or cis-trans 
prolyl isomerization in the ER,82 leading to ER stress. Hypoxia can occur in adipose 
tissue in the setting of obesity, probably as a result of the diffusion limit of oxygen 
imposed by the hypertrophic adipocytes. Adipocyte hypoxia has been shown to be 
associated with the induction of ER stress and increased expression of CHOP, which 
is at least partly responsible for the reduced expression of adipocytokines that 
provide important anti-inflammatory functions.83 This raises the possibility that 
hypoxia-induced ER stress may be linked to obesity-related metabolic diseases.  
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Hypoxia, due to inefficient vascularization, is also a hallmark of the tumour 
microenvironment and is one of the factors that accounts for UPR activation in solid 
tumours. UPR activation in tumours triggers protective responses that enable the 
tumour to cope with conditions of low oxygen and nutrient supply.84  Splicing of 
XBP1 mRNA was recently shown to provide a survival benefit for highly aggressive 
triple negative breast cancer cells. Inhibition of XBP1 in these tumour cells using 
RNA interference decreased tumour growth and particularly affected angiogenesis, 
which links XBP1 to tumour hypoxia. Moreover, it was shown that XBP1 directly 
interacts with the central mediator of the cellular response to hypoxia, hypoxia-
inducing factor 1  (HIF1 ), and assists in regulating the expression of HIF1  target 
genes.85 As HIF1 also has a prominent role in the anti-tumour immune response by 
inhibiting the effector functions of tumour-infiltrating lymphocytes,86 targeting the 
UPR and HIF1 as connected pathways in solid tumours might provide a therapeutic 
benefit in boosting anti-tumour immune responses. 
 
[H3] Reactive oxygen species 
The oxidizing environment of the ER is optimized for disulfide bond formation and 
the redox status of the ER is tightly regulated in mammalian cells.87 This 
environment is primarily derived from ROS generated by endoplasmic reticulum 
oxireductin 1 (ERO1), with protein disulfide isomerase being responsible for 
disulfide bond formation. However, cellular ROS production increases significantly 
and to supraphysiological levels under ER stress and inflammatory conditions. 
These conditions are closely connected in a reciprocal manner such that they induce 
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self-reinforcing pathways that may further promote inflammation.4,88  ROS can be 
induced by a wide variety of immunological signals. These include, for example, TLR 
and TNF receptor signaling, which further trigger inflammatory responses by 
enhancing the phosphorylation of IB to induce nuclear factor- B (NF- B) 
signaling.89 Conversely, it has been shown that extracellular sources of ROS can 
induce ER stress, possibly by disrupting Ca2+ retention in the ER.90  Once they are 
produced, ROS can also promote NLRP3 inflammasome activation91 and regulate 
lymphocyte function89 and, as discussed above, NOX2-derived ROS in macrophages 
are required for XBP1-dependent cytokine production upon TLR2 and TLR4 
ligation.  
In mouse models of diabetes, ER stress and ROS production have recently been 
linked to inflammasome activation and pancreatic -cell death in a pathway 
involving the induction of thioredoxin-interacting protein (TXNIP). This protein 
interacts with thioredoxin and reduces its anti-oxidant effect. Two recent studies 
have shown that ER stress-induced inflammasome activation and pancreatic -cell 
apoptosis were preceded by increased Txnip mRNA expression through a pathway 
involving IRE1 27 and/or PERK.92 As a consequence, genetic deletion of TXNIP 
partly protects against diabetes progression.27 
 
[H3] Pathogens 
Many pathogens interfere with the function of host ER as part of their infectious life 
cycle, and therefore can activate distinct arms of the UPR. Pathogen-induced UPR 
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activation can be beneficial to the host by functioning to enable an innate immune 
response directed against invading pathogens. However, invading pathogens can 
selectively modulate UPR pathways to promote their own survival. 93 
Viral replication requires the host ER for the production of viral structural and non-
structural proteins and as such interferes with the host protein synthesis  
machinery.94 Unsurprisingly, viral infection can trigger the UPR (excellently 
reviewed in REF 95).95 The IRE1 -mediated arm of the UPR can block viral 
replication in the case of respiratory syncytial virus (RSV), probably through RIDD-
dependent viral RNA degradation, as XBP1 is not required for defence against RSV. 
96 However, some viruses, such as Japanese encephalitis virus, use RIDD to their 
advantage to degrade host RNAs without affecting viral RNA.97  Similarly, many 
viruses have evolved mechanisms to circumvent the disadvantageous consequences 
of the UPR; selective activation of the ATF6 - and IRE1 -mediated arms of the UPR 
sustains viral replication by increasing the production of ER chaperones, while at 
the same time viruses block PERK-mediated UPR activation to circumvent a 
translational block and/or ER stress-induced apoptosis. For example, herpes 
simplex virus type 1 selectively blocks activation of the PERK-mediated arm of the 
UPR by association of viral glycoprotein gB with the luminal domain of PERK.98  
Also, whereas hepatitis C virus (HCV) induces IRE1  and ATF6  activation, the virus 
suppresses the downstream effects of XBP1s to prevent activation of ERAD, which 
enables HCV replication and contributes to persistence of the virus in infected 
hepatocytes.99,100 
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An important example of how the UPR protects the host from bacterial infection 
comes from studies in Caenorhabditis elegans. In this nematode, infection with 
Pseudomonas aeruginosa induces a p38 MAPK-driven innate immune response, 
which in turn triggers the IRE1 –XBP1 pathway of the UPR. XBP1 activation is 
protective for the host as xbp1-mutant larvae exhibit ER disruption and increased 
lethality in response to infection. Interestingly, lethality could also be prevented by 
loss of p38 MAPK, which shows that it is not the infection itself but rather the innate 
immune response that is lethal in the absence of a simultaneous protective XBP1-
dependent UPR response.101 
A recent study in primary bronchial epithelial cells further supports the link 
between an innate immune response and the UPR by showing that virulence factors 
derived from P. aeruginosa strongly induce UPR activation in a p38 MAPK-
dependent manner, as evidenced by Xbp1 splicing and the induction of BiP and 
CHOP. However, induction of GADD34 occurred through activation of the ISR, which 
was associated with improved survival of host cells.102    
L. monocytogenes has a well-documented ability to induce the UPR, which was 
recently shown to occur without active infection of cells by secretion of the cytolysin 
listeriolysin O. This toxin induces all branches of the UPR, possibly by altering 
intracellular Ca2+ homeostasis, which leads ultimately to apoptosis.103   Similarly, the 
AB5 subtilase cytotoxin from Shiga-toxigenic Escherichia coli cleaves BiP, thus 
inducing all three arms of the UPR and resulting in ER stress-induced cell death.104 
Pathogen associated molecular patterns may also activate specific arms of the UPR. 
As an example, Streptomyces sp. produce a toxin (trierixin) that directly inhibits 
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Xbp1 splicing.45 By contrast, TLR2 and TLR4 ligands trigger the IRE1 –XBP1 arm of 
the UPR in macrophages while suppressing ATF4–CHOP signaling to promote 
macrophage survival during infections.70,76 Thus, pathogens can either subvert or 
induce the UPR during their life cycles, which in the latter case may alert the 
immune system to their presence. 
 
[H3] Cell damage and immunogenic cell death 
Dying cells can elicit inflammatory responses through the induction of cell surface 
receptors that are recognized by immune cells, such as the ER-resident protein 
calreticulin (CRT), or through secreted factors including high mobility group box 1 
(HMGB1) and ATP.105,106 HMGB1 activates all arms of the UPR in endothelial cells, 
resulting in increased expression of intercellular adhesion molecule 1 (ICAM1) and 
P-selectin, which probably function to attract immune cells to dying cells.107  In 
splenic DCs, HMGB1 exposure induces UPR activation with increased levels of BiP 
and Xbp1 splicing; this pathway seems to be important in mounting an immune 
response, as silencing Xbp1 is associated with downregulation of the costimulatory 
cell surface receptors CD80 and CD86, decreased MHC class II expression and, 
subsequently, impaired stimulation of T cells in co-culture systems.108   
Even before cells die and intracellular components such as HMGB1 are released to 
elicit inflammation, stressed cells induce immune responses; for example, the cell 
surface expression of CRT is a recognition signal for engulfment by antigen-
presenting cells. Human bladder carcinoma T24 cells exposed to photodynamic 
therapy, which causes ROS-mediated induction of ER stress, increase their cell 
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surface expression of CRT and secretion of ATP through PERK-orchestrated 
pathways.109 Interestingly, this was associated with increased engulfment of cancer 
cells by DCs and increased DC expression of CD80, CD86 and MHC class II, as well as 
increased IL-1  and nitric oxide production, all of which are important for an 
effective antitumor CD8+ T cell response.109 Increased cell surface expression of CRT 
also occurs in a PERK-dependent manner in cancer cells that have nonphysiological 
increases in chromosome content (known as ‘hyperploidy’, which occurs in the early 
stages of various cancers), and is an important immunosurveillance system against 
hyperploidy in cancers.110 
Whether UPR activation can drive the specific upregulation of ligands recognized by 
innate immune cells, including natural killer cells, requires further research. 
Interestingly, CHOP has been linked to cell death in HCT116 cells through 
upregulation of death receptor 5 (DR5), a receptor for TNF-related apoptosis-
inducing ligand (TRAIL). However in this setting, DR5 drives apoptosis in a ligand-
independent manner through activation of caspase-8..111 In addition, it is important 
to recognize that although UPR activation in tumour cells can sometimes increase 
their immunogenicity and is therefore beneficial for the host, some tumours also 
take advantage of the UPR to prevent anti-tumour immune responses. [BOX 2]. 
Elucidating the crosstalk between UPR activation in tumour cells, the release of 
damage-associated molecules, cell surface receptor expression and immune 
activation is of great importance to improve anti-tumour immune responses.  
 
[H1] The UPR as an inflammatory nidus 
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ER stress is implicated in various chronic pathological conditions involving 
inflammation (such as metabolic diseases, inflammatory bowel diseases, 
atherosclerosis and neurodegenerative diseases, amongst others). Investigation of 
the pathogenic mechanisms involved reveals a reciprocal regulation between ER 
stress and inflammation — whereby ER stress can directly initiate inflammatory 
pathways and, in turn, pro-inflammatory stimuli such as ROS, TLR ligands and 
cytokines trigger ER stress — such that the resulting UPR activation can further 
amplify inflammatory responses.112  
 
[H3] ER stress-induced inflammatory signaling 
NF-κB, a master transcriptional regulator of proinflammatory pathways, is activated 
by the interaction of IRE1α with TRAF2 in response to ER stress, which leads to the 
recruitment of IκB kinase (IKK) and the phosphorylation and subsequent 
degradation of IκB. This releases NF-κB for translocation to the nucleus (Figure 
5).113 The PERK–eIF2α- and ATF6-mediated branches of the UPR activate NF-κB 
through different mechanisms to IRE1α. Engaging the PERK–eIF2α signaling 
pathway in response to ER stress halts overall protein synthesis and increases the 
ratio of NF-κB to IκB, owing to the shorter half-life of IκB, thereby favoring NF-κB-
dependent transcription (Figure 5).114,115 ATF6  activation through exposure to the 
bacterial subtilase cytotoxin can induce phosphorylation of AKT to activate NF-κB 
(Figure 5).116,117 
JNK, together with p38 and ERK, is one of the stress-inducible MAPKs that mediate a 
wide variety of responses, including but not limited to proliferation, autophagy and 
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inflammation. The IRE1α–TRAF2 complex can, in addition to the activation of NF- B, 
recruit apoptosis signal-regulating kinase 1 and subsequently activate JNK, leading 
to the increased expression of proinflammatory genes through enhanced activator 
protein 1 activity (Figure 5).118,119Loss of XBP1 in small IECs results in 
hyperactivation of IRE1 , which drives inflammatory responses, including cytokine 
production, that are in part mediated by phosphorylation of JNK.78 ER stress in 
human cancer cell lines has also been shown to trigger ERK activation through PI3K, 
which was associated with increased resistance to ER stress-induced cell death120 
UPR activation in immune cells and various stromal cells leads to the induction and 
secretion of various cytokines, such as IL-6 and TNF.121,122 In macrophages, XBP1s 
directly binds the Tnf and Il6 promoters to regulate their expression,70  and ATF4, 
downstream of PERK activation, functions as a transcription factor for Il6 (Figure 
5).75 ER stress in pancreatic β cells can trigger activation of the NLRP3 
inflammasome and IL-1β secretion through IRE1α- and PERK-mediated induction of 
TXNIP (Figure 5).27 
Conversely, cytokines themselves can directly regulate the UPR. Interleukin 10, for 
example, can inhibit inflammation-induced ER stress by blocking shuttling of 
ATF6p50 to the nucleus in a pathway that involves p38 MAPK.123  However, 
circulating pro-inflammatory cytokines including IL-1, IL-6, CXCL8 (also known as 
IL-8) and TNF, can trigger UPR activation in the liver and thereby stimulate the 
release of products of the acute phase response (APR) [G], which amplify 
inflammatory responses to eliminate infection and restore tissue homeostasis. Upon 
ER stress in hepatocytes, ATF6  and CREBH traffic to the Golgi to undergo S1P- and 
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S2P-mediated cleavage; the cytosolic active transcription factors that are released 
induce expression of APR genes including C-reactive protein and serum amyloid P 
component (Figure 5).112 
 
[H1] The ‘pathological’ UPR in inflammatory disease 
UPR-associated inflammatory pathways are increasingly recognized to be involved 
in a variety of complex inflammatory diseases.  In the sections below, we discuss 
several examples of autoimmune, metabolic and neoplastic conditions in which the 
UPR may play a significant role. 
[H3] Inflammatory bowel disease 
Over the past decade, genome wide association studies (GWAS) have identified 
various susceptibility loci for Crohn disease [G] and ulcerative colitis [G], which are 
chronic inflammatory diseases of the gastrointestinal tract, collectively known as 
inflammatory bowel disease (IBD).124, 125 Many of these risk genes encode proteins 
that have an important role in proteostasis. Orosomucoid-like 3 (ORMDL3), a risk 
locus for both Crohn disease126 and ulcerative colitis127 (as well as interestingly 
asthma128), encodes an ER trans-membrane protein that in lung epithelial cells 
activates ATF6  and induces expression of SERCA2B (also known as ATP2A2), 
which might be associated with airway remodeling.128 In addition, ORMDL3 
represses serine palmitoyltransferase activity and thereby decreases ceramide 
levels, which might protect from apoptosis.129  However, the mechanism by which 
ORMDL3 is involved in IBD pathogenesis is unstudied. Candidate gene approaches 
have also identified anterior gradient 2 (AGR2)130 and XBP1 as risk loci for Crohn 
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disease and ulcerative colitis. AGR2 is a member of the protein disulfide isomerase 
family and is particularly highly expressed by secretory cells of the intestinal tract. 
In line with this, Agr2–/– mice have decreased expression of mucin 2 (MUC2) in 
goblet cells and abnormal localization of Paneth cells in the small intestine, which 
coincides with UPR activation and the development of spontaneous ileocolitis.131  
Conditional deletion of Xbp1 in IECs causes ER stress and results in spontaneous 
inflammation of the small intestine and increased susceptibility to dextran sodium 
sulfate (DSS)-induced colitis.78 As for AGR2 deficiency, deletion of XBP1 in IECs 
particularly affects secretory cells, as Xbp1IEC mice have decreased numbers of 
goblet cells and severely hypomorphic Paneth cells with decreased antimicrobial 
peptide production, which is associated with increased susceptibility to infection 
with L. monocytogenes.78 It is not fully clear exactly how UPR activation in the AGR2-
deficient and Xbp1IEC mice eventually causes intestinal inflammation. Xbp1IEC mice 
show signs of IRE1 -dependent JNK phosphorylation and NF- B activation, and 
blockade of NF- B activation or genetic deletion of IRE1  in IECs or systemic 
deletion of TNF receptor 1 protects Xbp1IEC mice from spontaneous enteritis.79,124 
Thus, IRE1 –NF- B signaling, in a pathway that is driven by TNF, has a crucial role 
in the development of inflammation upon deletion of XBP1 in IECs.  
As autophagy compensates for ER stress [BOX 1], genetic deficiency of autophagy in 
Xbp1IEC mice is associated with even more severe spontaneous enteritis that 
extends transmurally.79 Indeed, signs of ER stress have been detected in Paneth cells 
in patients with Crohn disease carrying the risk allele of autophagy-related 16-like 1 
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(ATG16L1T300A).132  Moreover, as the ATG16L1T300A risk allele encodes a protein that 
is otherwise functionally intact but has increased sensitivity to caspase 3-mediated 
cleavage,133,134 and as XBP1 deletion in IECs leads to caspase 3 activation,78 it is 
possible that in humans environmentally and/or genetically determined ER stress 
can reveal the phenotypic manifestations of this common risk variant.135 The 
epithelium of the small intestine may be particularly sensitive to ER stress-induced 
caspase 3 activation and ATG16L1T300A cleavage as there is evidence for ER stress 
even under baseline, non-inflammatory conditions.136 
In addition to IRE1 , the intestinal and lung epithelia express IRE1  (encoded by 
Ern2), particularly in goblet cells. Ern2–/– mice have increased basal levels of BiP in 
the intestinal epithelium, aberrant MUC2 accumulation in the ER of goblet cells137 
and increased sensitivity to DSS-induced colitis.138   
Various other perturbations in UPR signaling have been associated with intestinal 
inflammation. Mice lacking CREB3L1 (also known as OASIS),139,140 ATF6  or p58IPK 
(also known as DNAJC3) are more susceptible to DSS-induced colitis.138 
Furthermore, nonphosphorylatable Ser51Ala eIF2 -mutant mice have defective 
UPR signaling in IECs, leading to secretory dysfunction of Paneth cells and increased 
sensitivity to oral Salmonella infection and DSS-induced colitis.141  
Forward genetic approaches using N-ethyl-N-nitrosourea mutagenesis have yielded 
mouse strains (named Winnie and Eeyore) that carry single missense mutations in 
Muc2. These mutations cause misfolding of MUC2 protein, which results in strong 
UPR activation and spontaneous ulcerative colitis-like colitis, characterized by 
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inflammatory responses that involve both innate and adaptive immunity (including 
the IL-23–T helper 17 cell inflammatory axis).142,143 
Together, these studies show that the UPR is important in maintaining intestinal 
epithelial homeostasis in response to a highly complex intestinal luminal 
environment challenged by microrganisms and other external factors. However, 
intestinal inflammation can also be promoted by ER stress in the haematopoietic 
system of mucosal tissues, as shown by studies in HLA-B27 transgenic rats,144  and 
the contributions of UPR activation in distinct cell types to intestinal inflammation 
requires further research. 
 
[H3] Diabetes mellitus 
Pancreatic -cells rapidly increase protein synthesis during acute and chronic 
stimulation and are therefore dependent on a well-developed ER and protein quality 
control mechanisms. -cell-specific deletion of IRE1  or XBP1 results in impaired -
cell proliferation, defective proinsulin synthesis and processing, and decreased 
insulin secretion,145  Similarly, genetic deletion of PERK leads to ER stress-induced 
loss of pancreatic -cells and a progressive decline in endocrine (but also exocrine) 
pancreatic function, with hyperglycaemia developing within 4 weeks,146 which 
further emphasizes the central role of the UPR in pancreatic -cell survival and 
diabetes. In Akita mice, the oxidative folding of proinsulin by ER-resident 
oxireductases, which is required to obtain the native shape of proinsulin and allow 
its trafficking from the ER further down the secretory pathway, is impeded by the 
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expression of a mutant form of proinsulin (Ins2 C96Y). This results in the 
accumulation of misfolded proinsulin proteins in the ER, which triggers UPR 
activation, -cell inflammation and eventually -cell death, and leads to diabetes as 
early as 4 weeks of age,147,148 similarly to PERK-deficient mice.149 Importantly, 
IRE1α oligomer formation, which is indicative of high and chronic ER stress, is a 
crucial propagator of the phenotype of Akita mice, as pharmacological inhibition of 
IRE1α kinase activity alleviates the disease phenotype.26  
ER stress-induced JNK activation occurs in adipose and liver tissue of obese mice, 
whether induced by high fat diet or genetically through leptin deficiency (ob/ob 
mice). Obese mice develop insulin resistance through ER stress-mediated JNK-
induced phosphorylation of insulin receptor substrate 1, which impairs insulin 
action and causes insulin resistance. However, overexpression of spliced XBP1 
protected these mice from insulin resistance.150 Importantly, lower levels of spliced 
XBP1 in livers of obese mice were recently shown to result from inducible nitric 
oxide synthase (iNOS)-dependent — and thus inflammation-dependent — S-
nitrosylation of the RNase domain of IRE1 , while the kinase domain was 
unaffected; this resulted in decreased levels of protective XBP1s but maintained the 
levels of pro-inflammatory phosphorylated JNK. This study thereby demonstrates 
how obesity-induced inflammation can alter UPR signaling and provides a new link 
between inflammation, UPR activation and metabolic dysfunction.151 
ROS production secondary to ER stress can be another trigger for inflammation as it 
activates the NLRP3 inflammasome and IL-1β secretion in β-cells through increased 
levels of TXNIP, either as a result of RIDD-dependent decay of the Txnip-suppressing 
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microRNA miR-17 or through the PERK pathway, ultimately leading to β-cell 
apoptosis and diabetes.27,92 Indeed, suppression of JNK activity protects -cells from 
oxidative stress and ameliorates glucose tolerance.152 Although this is a field of 
extensive research, much still needs to be learned about the interplay between ER 
stress, inflammation and the development of metabolic diseases such as diabetes, as 
the UPR could be an attractive signaling pathway for therapeutic intervention. 
 
[H3] Non-alcoholic steatohepatitis 
The crucial role of the UPR in the liver was first discovered in 2000, when it was 
shown that XBP1 was required for liver development.153 In the liver, the ER and UPR 
are highly important for lipid synthesis and metabolism, in addition to their well-
known role in protein quality control.154  UPR activation in the liver has been 
extensively studied in light of the increasing prevalence of non-alcoholic fatty liver 
disease (NAFLD) [G], which is the foremost cause of non-alcoholic and non-viral 
liver–associated illness and death in the United States.155 Hepatic steatosis, the 
mildest form of NAFLD, can progress to non-alcoholic steatohepatitis (NASH), 
through a process that involves free fatty acid and lipid accumulation in hepatocytes 
followed by a series of innate immune responses in leukocytes including liver-
resident macrophages known as Kupffer cells.156 It has been shown that ER stress 
can induce liver steatosis through effects on lipid synthesis and inflammation, but 
high fat feeding-induced steatosis itself can also trigger ER stress, thereby providing 
a positive feedback loop that amplifies liver inflammation and injury.157 In turn, UPR 
activation can modulate inflammatory signaling to induce liver inflammation, in part 
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through JNK activation, and IkB phosphorylation leading to NF-kB activation,113,114 
which is an important mediator of methionine- and choline- deficient (MCD) diet-
dependent development of NASH.158 In addition, the accumulation of lipids in 
hepatocytes can lead to mitochondrial dysfunction with increased ROS levels, which 
further triggers downstream inflammatory responses. The importance of ROS in the 
development of NASH had specifically been shown in mice deficient in NRF2, a 
protein that is crucially involved in the antioxidant response and can be induced by 
PERK; Nrf2–/– mice develop NASH more rapidly than wild-type mice when fed high-
fat, high-cholesterol or MCD diets.159    
 
[H3] Cancer 
Activation of the UPR in cancers can initiate transcriptional programmes that allow 
them to combat harsh environmental conditions such as hypoxia, oxidative stress 
and low nutrient availability. In addition, these transcriptional programmes can 
actively shape a tumourigenic proinflammatory milieu. For example, UPR activation 
in prostate cancer cells results in transcriptional upregulation of IL6 and TNF,160 the 
promotors of which contain functional binding sites for XBP1s,70 proinflammatory 
mediators that may promote inflammation-induced malignancies.161,162 Moreover, 
both the PERK-163 and IRE1 164 arms of the UPR in tumour cells can 
increase transcription of genes encoding pro-angiogenic mediators such as vascular 
endothelial growth factor A, fibroblast growth factor 2 and IL-6.163-165 
Intriguingly, UPR activation in cancer cells can also affect the anti-tumour immune 
response. Soluble factors secreted by ER-stressed tumour cells, but not non-stressed 
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tumour cells, can upregulate pro-inflammatory cytokine expression in macrophages, 
including the tumorigenic cytokines IL-6, IL-23p19 and TNF.166  These soluble 
factors are also involved in dampening the anti-tumour immune response by 
inhibiting antigen presentation by APCs to cytotoxic CD8+ T cells.66,167 The 
mechanism by which this occurs is only partly elucidated but may include ROS-
induced ER stress in DCs, transmitted through a yet to be defined factor, which 
increases lipid synthesis through XBP1 activation and thereby disrupts antigen 
presentation.66 
 
[H1] Conclusions  
Much has been learned about the functions of the UPR beyond being simply a means 
to cope with ER stress. The UPR has now also been recognized for its role in immune 
cell differentiation and function, and in regulating immune and inflammatory 
responses, including those associated with infections, tumours and autoimmune 
responses. It is clear that the UPR, and thus a certain level of ER stress, is crucial for 
cellular and consequently tissue homeostasis (the ‘eustress’ response). Therefore, 
understanding how the balance tips towards a pathophysiological UPR (the 
‘distress’ response) that is associated with disease, and how this balance can be 
manipulated to enable appropriate immune responses and restore homeostasis, are 
important future research directions. 
With the development of therapeutic agents that enhance proteostasis or interfere 
with specific components of the UPR [BOX 3], used either alone or together, the 
hope is that an improved understanding of the UPR in immunity and inflammation 
 33 
will eventually lead to the development of novel therapeutic strategies for chronic 
immune-mediated diseases. 
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BOX 1 | Autophagy as a compensation strategy for ER stress 
In response to the challenge of misfolded proteins, autophagy has a crucial function 
as an adaptive, “self-eating” process in which cellular components are encapsulated 
within autophagosomes and degraded. Similarly to the unfolded protein response 
(UPR), autophagy can result in cell survival or cell death.168 169  The mechanisms by 
which the UPR induces autophagy are incompletely understood, but probably 
involve PERK–eIF2α and IRE1α signaling.170 
ATF4 and CHOP function both independently and together to induce a large array of 
autophagy genes.171 In addition, eIF2  phosphorylation, in response to polyQ72 
aggregate-induced ER stress, is associated with autophagosome formation and 
protection against neuronal cell death.43 In another example, using unfolded 
dysferlin as a model of muscular dystrophy, XBP1s was shown to be crucial for 
autophagy induction and protection from neurodegeneration.172 Furthermore, UPR 
pathways can activate AMPK, which attenuates AKT–mTOR signaling to enhance 
autophagy.173 
A direct demonstration that autophagy can compensate for ER stress derives from 
studies of ER stress-induced small intestinal inflammation,78  whereby concomitant 
deletion of epithelial XBP1 and of epithelial associated autophagy related protein 7 
(ATG7) or ATG16L1 results in increased ER stress and severe transmural Crohn 
disease-like enteritis, compared with deletion of XBP1 alone, which only induces 
mild superficial inflammation (Figure 4C). In this model, the induction of autophagy 
depends on phosphorylation of eIF2 .79 In the case of intestinal epithelial stress 
associated with inflammatory bowel disease, autophagy probably functions to 
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selectively remove inflammatory ER membranes (vide infra). In the setting of 
cancer, ER stress induces activation of the PERK–eIF2α–ATF4 signaling pathway to 
increase tumour cell survival through the induction of autophagy.174 175 The precise 
mechanism by which autophagy relaxes ER stress remains unclear. Autophagy was 
previously considered to be a non-specific process (bulk macro-autophagy), but 
selective autophagy processes that precisely target organelles such as mitochondria 
and peroxisomes into autophagosomes have now been described. Autophagy of the 
ER (ER-phagy) has been described in yeast,176  and more recently also in 
mammalian cells. In mammalian cells, ER-phagy depends on the FAM134 reticulon 
family of proteins, which function as ER transmembrane receptors binding LC3 and 
GABARAP, thereby initiating ER degradation by autophagy.177 It remains to be 
determined whether autophagy directly degrades stressed ER membranes 
containing misfolded proteins, and whether FAM134 proteins or the selective 
autophagy receptors NBR1, optineurin, p62 or NDP52 are involved. 
 
BOX 2 | Transmission of ER stress 
Can immune cells sense ER stress in other cells? Intriguing studies have shown that 
activation of the unfolded protein response (UPR) in tumour cells can, through an 
unknown transmissible factor, induce ER stress in macrophages involving 
upregulation of BiP, Chop and Gadd34 mRNAs and increased splicing of Xbp1. This 
occurs in a TLR4-dependent manner, which suggests that a TLR4 ligand is the 
transmissible factor. Importantly, ER stress-induced cell death was not responsible 
for the observed transmissible ER stress, which indicates that there is active 
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secretion of the transmissible factor rather than passive leakage of damage-
associated molecules from dying cells.166 Macrophages that were stimulated by 
neighboring ER-stressed tumour cells had increased inflammatory responses, which 
is in keeping with previous observations that TLR4 ligation amplifies pro-
inflammatory cytokine signaling and may be the responsible signaling moiety.70 
Apart from macrophages, dendritic cells (DCs) are also susceptible to an ER stress-
transmissible factor secreted by tumour cells, which interferes with DC-mediated 
cross-presentation to CD8+ T cells and results in a less effective anti-tumor immune 
response.167 It was recently shown that XBP1s-induced increases in lipid 
metabolism in DCs could be the underlying mechanism of impaired MHC class I-
mediated antigen presentation to cytotoxic T cells.66   
It is not clear whether the unidentified transmissible factor is a byproduct of ER 
stress in tumour cells or is actively secreted by these cells to modulate the anti-
tumour response. Identification of the ER stress-transmissible factor would greatly 
enhance our understanding of how tissue-specific ER stress can become systemic in 
nature. In addition, this could provide possible new therapeutic targets to improve 
the anti-tumour immune response. 
 
BOX 3 | Therapeutic opportunities 
Tauro-ursodeoxycholic acid (TUDCA) and 4-phenyl butyrate (PBA) are small 
molecule chaperones that contribute to proper protein folding in the ER; they have 
proved successful in alleviating ER stress-induced hyperglycaemia, restoring insulin 
sensitivity and ameliorating fatty liver disease in obese mice.178 TUDCA and PBA 
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have also been shown to reduce ER stress in the intestinal epithelium and thereby 
decrease the severity of DSS-induced colitis.179 In addition, LPS-induced lung 
inflammation was reduced by PBA, through decreasing ER stress and modulating 
NF- B and HIF1  signaling pathways.180  
In haematological malignancies that produce large amounts of protein, such as 
multiple myeloma, blocking the 26S proteasome with bortezomib induces activation 
of the PERK-mediated unfolded protein response (UPR) pathway, which increases 
ATF4 and CHOP activity and sensitizes multiple myeloma cells to apoptosis.181  In 
addition, blockade of IRE1  endonuclease activity with the small molecule inhibitor 
MKC-3946 increases multiple myeloma cell toxicity in response to the proteasome 
inhibitor bortezomib.182  In line with this, CD138+ plasma cells from patients with 
multiple myeloma are highly prone to cell death after treatment with STF-083010, 
another specific IRE1  RNase domain inhibitor, which further illustrates the 
importance of XBP1 in plasma cells. In addition, STF-083010 has potent cytotoxic 
effects in multiple myeloma cell lines and xenograft models.183 
Sunitinib is a receptor tyrosine kinase inhibitor that targets the receptors for 
platelet-derived growth factor and vascular endothelial growth factor and thereby 
affects tumour angiogenesis and tumor cell proliferation. It has been FDA approved 
for the treatment of renal cell carcinoma and gastrointestinal stromal tumours. 
However, sunitinib also seems to influence the kinase activity of IRE1 184 and PKR-
dependent phosphorylation of eIF2 .185  Therefore, sunitinib is potentially beneficial 
for the treatment of UPR-prone cancers, but it has also been shown to have negative 
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effects on the anti-viral immune response, as measured by decreased levels of IFN-  
in response to infection with encephalomyocarditis virus, which was dependent on 
decreased RNase L activity.185 This study exemplifies that broadly targeting the UPR 
might have important side effects that must be considered.  
Lastly, given the recent reports showing that UPR activation in cancers can 
modulate the tumour immune microenvironment, antigen presentation by dendritic 
cells and thereby anti-tumour responses, targeting the UPR in cancers may improve 
tumour recognition by the immune system or, synergistically, improve the efficacy 
of immunotherapy in cancer.  
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Figure legends 
Figure 1: Accumulation of unfolded proteins in the ER lumen induces the three 
arms of the UPR. A) Dissociation of BiP from IRE1 , or direct binding of misfolded 
proteins to IRE1 , activates the endoribonuclease domain of IRE1 , which non-
conventionally splices Xbp1u mRNA to produce a translational frameshift and create 
a potent transcriptional activator XBP1s. XBP1s activates the transcription of genes 
encoding proteins that are important for increasing the protein folding capacity of 
the ER and for the degradation of misfolded proteins via ERAD (see inset box). In 
addition, the entry of newly synthesized proteins into the ER is limited by the 
degradation of mRNA through regulated IRE1 -dependent decay of mRNA (RIDD). 
B) PERK-dependent phosphorylation of eIF2  inhibits ribosome assembly, which 
results in a translational block and allows the cell to cope with temporary ER stress. 
ATF4 escapes translation inhibition and induces the transcription of genes involved 
in downstream pro-survival pathways, including compensatory autophagy. Once ER 
stress is resolved, eIF2  is dephosphorylated by GADD34–PP1 to restore protein 
translation. However, if ER stress-induced damage is irreversible, the terminal UPR 
is activated to induce apoptosis, mainly through CHOP. C) Upon BiP dissociation 
from ATF6  during ER stress, ATF6  travels to the Golgi compartment where it is 
processed by the Golgi enzymes S1P and S2P to produce a cytosolic p50 fragment. 
ATF6p50 functions as a transcription factor that activates transcriptional 
programmes that increase ER capacity and protein folding, and that remove 
misfolded proteins from the ER for degradation (ERAD; see inset box). 
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Figure 2: XBP1 has a crucial role in plasma cell differentiation and dendritic 
cell differentiation and function. A: B cell receptor (BCR) ligation induces 
phosphorylation of B cell lymphoma 6 (BCL6) and its subsequent ubiquitylation and 
degradation. BCL6 degradation de-represses Blimp1 in naïve B cells to activate 
cellular programmes that are crucial for the development of plasma cells. These 
include activation of the unfolded protein response (UPR) and Xbp1 splicing, which 
is required for the expansion of the ER and increased protein (immunoglobulin) 
synthesis involved in plasma cell differentiation. B: Left panel: XBP1 is crucial for 
the differentiation of conventional DCs and plasmacytoid DCs from immature 
progenitors. Loss of XBP1 in progenitor cells abrogates maturation and decreases 
DC survival. Right panel, top: XBP1 deletion in mature CD11c-expressing DCs results 
in IRE1 hyperactivation leading to RIDD-dependent degradation of components of 
the MHC class I-mediated antigen cross-presentation machinery and, as such, ER 
stress in DCs interferes with their function. Right panel, bottom: In addition, 
increased XBP1s in response to ROS production in tumour DCs leads to augmented 
lipid biogenesis which is associated with disruption of MHC class I-mediated cross-
presentation. 
 
Figure 3: TLR signaling and the UPR coordinate immune responses in 
macrophages. A: Upon TLR ligation, the IRE1 –XBP1 arm of the unfolded protein 
response (UPR) is activated through a mechanism that requires TRAF6 recruitment 
to the TLR and ROS production by the NADPH oxidase NOX2. XBP1s functions as a 
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transcription factor to induce the transcription of pro-inflammatory cytokines Il6 
and Tnf . In a separate pathway, translation of Atf4 mRNA is inhibited by TLR4 
ligation, which decreases CHOP levels and apoptosis in activated macrophages and 
thereby facilitates the immune response by favoring macrophage survival. B: In the 
absence of TLR signaling, phosphorylated IRE1  is subject to protein phosphatase 
2A (PP2A)-mediated dephosphorylation and inactivation (left panel). Upon TLR 
ligation however, TRAF6 interacts with IRE1  and catalyzes the ubiquitylation of 
IRE1 , which prevents PP2A-mediated dephosphorylation and inactivation of 
IRE1 , thereby amplifying inflammation (right panel). C: IRE1  activation can 
induce Il1  transcription through GSK3 , which at the same time inhibits Xbp1 
splicing and thereby transcription of XBP1s target genes including Tnf. 
 
Figure 4: A) Intestinal epithelial cells, particularly Paneth cells, have a well 
developed ER to cope with the high secretory demands, including production of 
antimicrobial proteins such as lysozyme and defensins. B) Deletion of XBP1 in the 
small intestinal epithelium (Xbp1IEC mice) induces ER stress, resulting in 
hypomorphic Paneth cells that have signs of IRE1  hyperactivation and downstream 
activation of NF- B and JNK. Induction of autophagy through the PERK–eIF2 –ATF4 
axis of the UPR alleviates ER stress. C) Simultaneous deletion of XBP1 and ATG16L1 
in the small intestinal epithelium therefore further increases ER stress and ER 
stress-induced inflammation. Hypothetically, ER stress, which induces caspase 3, 
could be an important pathway responsible for the degradation of ATG16L1 in 
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patients carrying the Crohn disease risk allele Atg16L1T300A which is prone to 
caspase 3-mediated cleavage. 
 
Figure 5: the UPR as an inflammatory nidus. A) IRE1  activation and subsequent 
splicing of Xbp1 produces the transcription factor XBP1s that directly binds the 
promoters of Tnf and Il6. B) RIDD-dependent degradation of miR-17, which in 
unstressed conditions represses Txnip, allows for increased TXNIP levels and NRLP3 
inflammasome activation with upregulation of IL-1 . In addition, Txnip can be 
induced through the PERK–ATF5 pathway to induce inflammasome activation. C) 
Activated IRE1  forms a complex with TRAF2 to induce phosphorylation of JNK and 
upregulation of pro-inflammatory genes through AP1-activated transcription. D) In 
addition, the IRE1 –TRAF2 complex recruits IKK and subsequent phosphorylation 
of I B leads to its degradation, thereby freeing NF- B for nuclear translocation. E) 
Translation attenuation by PERK-dependent phosphorylation of eIF2  results in 
decreased I B and NF B translation. However, owing to the shorter half-life of I B, 
the result is an increased NF B to I B ratio, which promotes inflammation. F) ATF4 
directly binds the Il6 promotor. G) ATF6 induces NF B signaling via AKT 
phosphorylation. H,I) S1P- and S2P-mediated cleavage of ATF6  and CREBH allows 
their cleavage fragments to translocate to the nucleus and induce genes of the acute 
phase response (APR).  
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Glossary 
ER-associated degradation 
(ERAD). A pathway that removes terminally misfolded proteins from the ER through 
their retrotranslocation to the cytosol and that targets them for degradation by the 
ubiquitin–proteasome system. 
Unfolded protein response 
(UPR). A highly conserved pathway that regulates the balance between folding 
capacity of the endoplasmic reticulum (ER) and protein synthesis.  
Integrated stress response 
(ISR). An ancient stress response that modulates protein biosynthesis by integrating 
various types of stress signal, including ER stress, amino acid deprivation, virus 
infection and oxidative stress. 
Paneth cells 
Highly specialized small intestinal epithelial cells that shape the composition of the 
microbiota by the secretion of antimicrobial proteins and that sustain and modulate 
epithelial stem cells by the secretion of niche factors. 
Acute phase response 
(APR). A group of systemic and innate physiological processes in the early response 
to infection or injury.  
Crohn disease 
An inflammatory disease of the small and large intestines that is thought to arise 
from an inappropriate immune response towards the intestinal microbiota in a 
genetically susceptible host. 
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Ulcerative colitis 
A chronic disease of the colon with unknown aetiology, characterized by 
inflammation and ulceration of the colon. 
Non-alcoholic fatty liver disease 
(NAFLD). Liver disease characterized by the accumulation of fat (steatosis) in the 
liver, which is often associated with obesity. Although NAFLD is benign, it can 
progress towards steatohepatitis and even cirrhosis.  
 
Key points 
1. The unfolded protein response (UPR) has an important role in the 
differentiation and maturation of various immune cells and is crucial for 
immune cell function, such as cytokine production by macrophages and 
cross-presentation of dendritic cells, for example.  
2. Innate immune signaling differentially affects the three arms of the UPR to 
optimize inflammatory responses, while at the same time inhibiting the 
activation of the terminal UPR, which is associated with cell death. This 
allows the cell to survive and cope with temporary increases in protein 
production during immune responses to pathogens. 
3. In complex autoimmune diseases, chronic activation of the UPR can function 
as the nidus for the development of inflammation. 
4. UPR activation triggers inflammatory responses mainly through NF-kB 
activation, phosphorylation of JNK, activation of the inflammasome or direct 
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interaction of downstream UPR targets with the promoters of inflammatory 
cytokine genes. 
5. UPR activation in cancer cells may interfere with anti-tumour immunity, 
which indicates that manipulating UPR signaling could boost anti-tumor 
immune responses. 
6. The UPR is amenable to therapeutic manipulation to either promote its 
beneficial homeostasis-inducing properties and/or inhibit its inflammation-
inducing activities in the setting of unresolved ER stress. 
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